ÂÜÀòÂÒÂ×

Kristie Lauterbach, Senior Director of Quality Assurance, brings over 25 years of progressive quality leadership and experience in the pharmaceutical industry to Lung Therapeutics. Most recently, Ms. Lauterbach provided Quality leadership at Takeda, where she had oversight for the technical transfer and supplier management of two key products from API through packaging operations. Prior to Takeda, Ms. Lauterbach was the Head of Quality for Catalent Pharma Solutions, responsible for quality assurance, quality control, validation, GMP Compliance, DEA Compliance, Microbiology, document control, batch release, and supplier management at one of their key oral solid dosage sites. Before Catalent, Ms. Lauterbach spent ten years at Eli Lilly and Co., where she enjoyed leadership roles of increasing responsibility, including oversight of parenteral manufacturing, supplier quality management, and oversight for Lilly's external partners across medical/clinical development. Ms. Lautebach began her career at Amour Pharmaceutical (now known as CSL Behring) as an Aseptic Technician progressing into quality assurance and manufacturing leadership roles. Ms. Lauterbach holds a Bachelor's degree in Biology and an MBA from Olivet Nazarene University.